Pricing Log in Create free account

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs ImageneBio, Inc. (IMA)

Connect Biopharma Holdings Limited Sponsored ADR and ImageneBio, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and ImageneBio, Inc. are of similar size ($47.3M and $46.1M). ImageneBio, Inc. has the higher net margin (0.00% vs −2,298.9%) and the lower return on invested capital (−622.4% vs 0.00%). Across the 15 metrics below, ImageneBio, Inc. leads on 13 and Connect Biopharma Holdings Limited Sponsored ADR on 2.

Valuation

Metric CNTB IMA Biotechnology median
P/E n/m n/m 10.60
P/S 15.30 10.81 9.40
P/B 1.71 0.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.87 2.71 9.02
Earnings yield (163.01%) (136.60%) (32.88%)
Free cash flow yield (132.91%) (77.70%) (23.13%)

Profitability

Metric CNTB IMA Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (2,346.35%) 0.00% 0.00%
Net margin (2,298.93%) 0.00% 0.00%
Free cash flow margin (2,018.76%) 0.00% 0.00%
Return on equity (140.51%) (41.34%) (51.96%)
Return on assets (109.34%) (38.34%) (46.06%)
Return on invested capital 0.00% (622.37%) 0.00%

Growth

Metric CNTB IMA Biotechnology median
Revenue growth (TTM) — (67.95%) 6.76%
EPS growth (last fiscal year) (257.14%) 56.38% 29.88%
Revenue growth, 5-year CAGR — (38.64%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTB IMA Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.37 21.47 4.97
Net debt to EBITDA 0.77 2.85 1.01

Dividend

Metric CNTB IMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTB IMA Biotechnology median
Market cap 46.08m 47.28m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack